• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短期使用布舍瑞林联合人绝经期促性腺激素对内分泌正常的女性进行卵巢刺激以用于体外受精。

Short-term use of buserelin in combination with human menopausal gonadotrophins for ovarian stimulation for in-vitro fertilization in endocrinologically normal women.

作者信息

Smitz J, Bollen N, Camus M, Devroey P, Wisanto A, Van Steirteghem A C

机构信息

Centre for Reproductive Medicine, Akademisch Ziekenhuis, Vrije Universiteit Brussel, Belgium.

出版信息

Hum Reprod. 1990 Feb;5(2):157-62. doi: 10.1093/oxfordjournals.humrep.a137061.

DOI:10.1093/oxfordjournals.humrep.a137061
PMID:2108989
Abstract

Ten endocrinologically normal women were injected subcutaneously with 500 micrograms D-Ser(TBU)6-EA10-LHRH (buserelin) on days 3,4 and 5 after the start of the menses. Two types of response were observed. Five women (group A) responded promptly and had a mean number of 13.4 oocytes retreived after 11.4 days of stimulation. In the second group (B), two to three times more HMG was needed to obtain a mean number of 7.3 oocytes after 17.2 days of stimulation. The response upon stimulation could be predicted by the serum gonadotrophin output on days 4 and 5 of the cycle. One woman from group B had a premature LH rise on day 16 and luteinization; her cycle was abandoned. In the four other patients of group B, serum and urinary LH concentrations showed that pituitary gonadotrophin secretion had recovered before the ovulatory stimulus, without signs of premature luteinization. Two women in each group became pregnant, one of whom aborted. This short-term GnRH agonist treatment could be an alternative method for ovarian stimulation, although it did not totally prevent the occurrence of an endogenous LH surge.

摘要

10名内分泌功能正常的女性在月经开始后的第3、4和5天皮下注射500微克D-丝氨酸(叔丁基)6-乙基酰胺10-促性腺激素释放激素(布舍瑞林)。观察到两种反应类型。5名女性(A组)反应迅速,在刺激11.4天后平均获得13.4个回收卵母细胞。在第二组(B组)中,需要两到三倍的人绝经期促性腺激素才能在刺激17.2天后平均获得7.3个卵母细胞。刺激反应可通过周期第4天和第5天的血清促性腺激素输出量来预测。B组的一名女性在第16天出现促黄体生成素过早升高和黄体化;她的周期被放弃。在B组的其他4名患者中,血清和尿促黄体生成素浓度显示,垂体促性腺激素分泌在排卵刺激前已恢复,无过早黄体化迹象。每组有两名女性怀孕,其中一名流产。这种短期促性腺激素释放激素激动剂治疗可能是卵巢刺激的一种替代方法,尽管它不能完全防止内源性促黄体生成素高峰的发生。

相似文献

1
Short-term use of buserelin in combination with human menopausal gonadotrophins for ovarian stimulation for in-vitro fertilization in endocrinologically normal women.短期使用布舍瑞林联合人绝经期促性腺激素对内分泌正常的女性进行卵巢刺激以用于体外受精。
Hum Reprod. 1990 Feb;5(2):157-62. doi: 10.1093/oxfordjournals.humrep.a137061.
2
Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT.对于体外受精(IVF)或配子输卵管内移植(GIFT)促排卵失败的患者,在人绝经期促性腺激素中添加布舍瑞林。
Hum Reprod. 1988 Oct;3 Suppl 2:35-8. doi: 10.1093/humrep/3.suppl_2.35.
3
The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women.促性腺激素释放激素(GnRH)激动剂在卵泡期对正常排卵女性体外受精结局的影响。
Hum Reprod. 1992 Sep;7(8):1098-102. doi: 10.1093/oxfordjournals.humrep.a137800.
4
Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.采用促性腺激素释放激素激动剂联合人绝经期促性腺激素控制的体外受精卵巢过度刺激。
Hum Reprod. 1986 Jan;1(1):15-9. doi: 10.1093/oxfordjournals.humrep.a136334.
5
Endocrine responses to gonadotrophins after LHRH agonist administration on cycle days 1-4: prevention of premature luteinization.在月经周期第1 - 4天给予促黄体生成素释放激素(LHRH)激动剂后对促性腺激素的内分泌反应:预防过早黄素化。
Hum Reprod. 1990 Apr;5(3):246-9. doi: 10.1093/oxfordjournals.humrep.a137081.
6
Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme.
Hum Reprod. 1987 Nov;2(8):655-6. doi: 10.1093/oxfordjournals.humrep.a136610.
7
Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.短期促黄体生成素释放激素激动剂治疗:一种用于体外受精的新型卵巢刺激方案的前瞻性试验。
Fertil Steril. 1989 Aug;52(2):264-9. doi: 10.1016/s0015-0282(16)60853-1.
8
Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?对于有发生卵巢过度刺激综合征风险的女性,是否有必要继续使用促性腺激素释放激素激动剂(GnRHa)?
Hum Reprod. 1992 Sep;7(8):1090-3. doi: 10.1093/oxfordjournals.humrep.a137798.
9
The use of the GnRH analogue buserelin for IVF--does it improve fertility?促性腺激素释放激素类似物布舍瑞林在体外受精中的应用——它能提高生育能力吗?
Br J Obstet Gynaecol. 1991 Jun;98(6):544-9. doi: 10.1111/j.1471-0528.1991.tb10368.x.
10
Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins.
Br J Obstet Gynaecol. 1985 Apr;92(4):369-73. doi: 10.1111/j.1471-0528.1985.tb01111.x.

引用本文的文献

1
Contemporary pharmacological manipulation in assisted reproduction.辅助生殖中的当代药理学操控
Drugs. 2004;64(3):297-322. doi: 10.2165/00003495-200464030-00005.